Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernanda Amary

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Nature Communications|July 19, 2013
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2Paul Guilhamon, Malihe Eskandarpour, Dina Halai, et al.
British Journal of Cancer|July 12, 2024
Introduction and impact of routine whole genome sequencing in the diagnosis and management of sarcomaJames A Watkins, Jamie Trotman, John A Tadross, et al.
Cancer Medicine|August 24, 2017
Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detectionAlice Gutteridge, Victoria M Rathbone, Rebecca Gibbons, et al.
Cancer Medicine|May 28, 2014
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapyM Fernanda Amary, Hongtao Ye, Fitim Berisha, et al.
Genome Biology|November 27, 2025
Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcomaWilliam Cross, Iben Lyskjær, Christopher Davies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 6, 2019
Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangementFernanda Amary, Luis Perez-Casanova, Hongtao Ye, et al.
British Journal of Cancer|November 16, 2024
UK guidelines for the management of bone sarcomasCraig Gerrand, Fernanda Amary, Hanny A Anwar, et al.
The Journal of Pathology|November 25, 2022
Recurrent FOSL1 rearrangements in desmoplastic fibroblastomaSolange De Noon, Robert Piggott, Jamie Trotman, et al.
The Journal of Pathology|December 15, 2018
Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of boneDaniel Baumhoer, Michal Kovac, Jan Sperveslage, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimicsNadège Presneau, Daniel Baumhoer, Sam Behjati, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Nature Communications|July 19, 2013
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2Paul Guilhamon, Malihe Eskandarpour, Dina Halai, et al.
British Journal of Cancer|July 12, 2024
Introduction and impact of routine whole genome sequencing in the diagnosis and management of sarcomaJames A Watkins, Jamie Trotman, John A Tadross, et al.
Cancer Medicine|August 24, 2017
Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detectionAlice Gutteridge, Victoria M Rathbone, Rebecca Gibbons, et al.
Cancer Medicine|May 28, 2014
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapyM Fernanda Amary, Hongtao Ye, Fitim Berisha, et al.
Genome Biology|November 27, 2025
Loss of IDH1 and IDH2 mutations during the evolution of metastatic chondrosarcomaWilliam Cross, Iben Lyskjær, Christopher Davies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 6, 2019
Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangementFernanda Amary, Luis Perez-Casanova, Hongtao Ye, et al.
British Journal of Cancer|November 16, 2024
UK guidelines for the management of bone sarcomasCraig Gerrand, Fernanda Amary, Hanny A Anwar, et al.
The Journal of Pathology|November 25, 2022
Recurrent FOSL1 rearrangements in desmoplastic fibroblastomaSolange De Noon, Robert Piggott, Jamie Trotman, et al.
The Journal of Pathology|December 15, 2018
Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of boneDaniel Baumhoer, Michal Kovac, Jan Sperveslage, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimicsNadège Presneau, Daniel Baumhoer, Sam Behjati, et al.
Pageof 8